See more : Xilio Therapeutics, Inc. (XLO) Income Statement Analysis – Financial Results
Complete financial analysis of PT Sarana Meditama Metropolitan Tbk (SAME.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Sarana Meditama Metropolitan Tbk, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- BIT Mining Ltd. (ADRs) (US0554741001.SG) Income Statement Analysis – Financial Results
- Reditus, Sociedade Gestora de Participações Sociais, S.A. (RED.LS) Income Statement Analysis – Financial Results
- COG Financial Services Limited (COG.AX) Income Statement Analysis – Financial Results
- Saudi Arabia Refineries Company (2030.SR) Income Statement Analysis – Financial Results
- Unicaja Banco, S.A. (UNI.MC) Income Statement Analysis – Financial Results
PT Sarana Meditama Metropolitan Tbk (SAME.JK)
About PT Sarana Meditama Metropolitan Tbk
PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Mahkota Teknologi Tbk.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,535.64B | 1,393.54B | 1,271.58B | 507.62B | 529.32B | 952.08B | 775.57B | 635.02B | 515.09B | 414.41B | 336.51B | 270.47B |
| Cost of Revenue | 1,101.60B | 916.61B | 729.02B | 275.58B | 316.84B | 527.03B | 418.93B | 339.26B | 261.38B | 210.57B | 172.22B | 149.84B |
| Gross Profit | 434.04B | 476.93B | 542.57B | 232.04B | 212.48B | 425.05B | 356.64B | 295.76B | 253.71B | 203.85B | 164.29B | 120.63B |
| Gross Profit Ratio | 28.26% | 34.22% | 42.67% | 45.71% | 40.14% | 44.64% | 45.98% | 46.58% | 49.26% | 49.19% | 48.82% | 44.60% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 122.24B | 117.14B | 97.41B | 58.55B | 45.89B | 62.00B | 46.99B | 44.58B | 39.08B | 31.86B | 26.85B | 20.80B |
| Selling & Marketing | 21.82B | 15.28B | 7.37B | 12.14B | 11.77B | 17.90B | 13.30B | 11.24B | 9.03B | 8.37B | 5.19B | 3.91B |
| SG&A | 393.56B | 132.42B | 104.78B | 70.69B | 57.66B | 79.90B | 60.29B | 55.81B | 48.11B | 40.24B | 32.04B | 24.71B |
| Other Expenses | 0.00 | 311.44B | 241.64B | 152.71B | 150.08B | -12.73B | -2.74B | -219.16M | 486.15M | 409.83M | -172.36M | -660.61M |
| Operating Expenses | 393.56B | 443.86B | 346.42B | 223.40B | 207.73B | 255.64B | 203.35B | 212.03B | 138.99B | 113.17B | 91.74B | 71.61B |
| Cost & Expenses | 1,488.31B | 1,360.47B | 1,075.44B | 498.97B | 524.57B | 782.67B | 622.28B | 551.29B | 400.37B | 323.74B | 263.96B | 221.45B |
| Interest Income | 6.03B | 6.80B | 12.72B | 933.99M | 111.47B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 75.98B | 46.21B | 41.09B | 109.73B | 111.47B | 72.76B | 53.31B | 43.24B | 22.50B | 23.44B | 21.42B | 20.39B |
| Depreciation & Amortization | 234.19B | 203.24B | 149.78B | 92.98B | 80.22B | 96.45B | 69.87B | 67.03B | 19.33B | 18.37B | 13.63B | 13.62B |
| EBITDA | 323.19B | 266.68B | 346.62B | 60.43B | 52.07B | 257.14B | 219.79B | 119.09B | 105.54B | 106.87B | 99.77B | 62.04B |
| EBITDA Ratio | 21.05% | 11.46% | 21.93% | 13.59% | 9.77% | 21.51% | 24.49% | 18.75% | 21.70% | 25.88% | 25.54% | 22.92% |
| Operating Income | 47.33B | 62.23B | 176.58B | 8.64B | 5.41B | 175.64B | 156.98B | 116.55B | 117.86B | 65.54B | 50.92B | 28.03B |
| Operating Income Ratio | 3.08% | 4.47% | 13.89% | 1.70% | 1.02% | 18.45% | 20.24% | 18.35% | 22.88% | 15.81% | 15.13% | 10.36% |
| Total Other Income/Expenses | -34.32B | -17.06B | -28.37B | -113.71B | -145.68B | -93.94B | -60.38B | -89.34B | -49.59B | -25.14B | -21.76B | -20.99B |
| Income Before Tax | 13.01B | 17.22B | 148.21B | -374.98B | -140.27B | 81.70B | 96.61B | 27.21B | 68.26B | 65.54B | 50.92B | 28.03B |
| Income Before Tax Ratio | 0.85% | 1.24% | 11.66% | -73.87% | -26.50% | 8.58% | 12.46% | 4.29% | 13.25% | 15.81% | 15.13% | 10.36% |
| Income Tax Expense | -4.73B | 7.64B | 156.46M | 74.48B | -25.89B | 22.82B | 24.59B | 12.42B | 11.66B | 7.47B | 4.27B | 4.76B |
| Net Income | 12.25B | 9.58B | 144.17B | -449.47B | -114.39B | 58.88B | 72.01B | 14.80B | 56.61B | 58.07B | 46.65B | 23.27B |
| Net Income Ratio | 0.80% | 0.69% | 11.34% | -88.54% | -21.61% | 6.18% | 9.29% | 2.33% | 10.99% | 14.01% | 13.86% | 8.60% |
| EPS | 0.71 | 0.56 | 10.64 | -43.85 | -12.62 | 6.50 | 7.94 | 1.63 | 6.24 | 6.36 | 5.17 | 2.57 |
| EPS Diluted | 0.71 | 0.56 | 10.64 | -43.85 | -12.62 | 6.50 | 7.94 | 1.63 | 6.24 | 6.36 | 5.17 | 2.57 |
| Weighted Avg Shares Out | 17.14B | 17.13B | 13.54B | 10.25B | 9.07B | 9.07B | 9.07B | 9.07B | 9.07B | 9.07B | 9.03B | 9.07B |
| Weighted Avg Shares Out (Dil) | 17.14B | 17.13B | 13.54B | 10.25B | 9.07B | 9.07B | 9.07B | 9.07B | 9.07B | 9.07B | 9.03B | 9.07B |
No news found for: SAME.JK
Source: https://incomestatements.info
Category: Stock Reports